Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


The Fertility Show


 

Back up your stem cells for £40,000

16 September 2013

By Antony Blackburn-Starza

Appeared in BioNews 722

A Singaporean-based company has become the first company to offer induced pluripotent stem (iPS) cell banking to the public. Scéil, part of the French company Cellectis, launched its service in the UK last July in the hope of attracting wealthy, and healthy, Britons to store their cells for possible future use.

The procedure, which is different from cord blood banking, involves taking a person's skin cells, which are then converted into iPS cells. These are then cryopreserved at minus 180 Celsius and stored at centres in Singapore, Dubai and Switzerland, the company's chief executive André Choulika has explained.

iPS cells are converted from adult cells into a embryonic-like state and have the ability to turn into almost any cells in the body. Researchers predict that stem cells could potentially be used in regenerative therapies to treat disease or repair damaged tissue and organs. However, regenerative techniques based on stem-cell technologies are still under development and have not yet reached therapeutic application with regulatory approval - although some clinical trials using iPS cells for the treatment of age-related macular degeneration are now underway in Japan (see BioNews 711).

'Scéil offers people the best possible chance in the future', said Mr Choulika. 'People should be able to "live young" no matter how old they grow. We're offering the potential for people to use their cells for their cure as soon as regenerative medicine treatments become available'.

Scéil's promotional material on its website states 'Don't delay, back yourself up today' and Mr Choulika is encouraging healthy people to start banking their cells earlier, rather than later.

'As time passes, your DNA is gradually altered. In order to have better stem cells, it's better to store them at an early, healthier stage', he said. 'If you want to preserve your genetic inheritance and background, it's better to freeze time immediately in the form of stem cells'.

Mr Choulika also explained the service is not for people who need immediate treatment, although he predicts we will begin to see the benefits of regenerative medicine in the next five years. Also, at a one-off investment of $60,000 - or around £40,000 - and an annual maintenance charge of $500 starting from the third year, Scéil's clientele is likely to be wealthy.

'We believe it's going to be very popular with a certain class of people who have everything they want but cannot go against ageing', said Mr Choulika. 'This is expensive, so only reserved for a certain class of people who can afford it'.

Mr Choulika explained the UK was chosen for the launch because it was able to operate in its regulatory environment; in France the service would not currently be permitted.

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

15 May 2017 - by Shaoni Bhattacharya 
One of the world's largest sets of human stem cell lines from healthy people was unveiled last week...
23 September 2013 - by Dr Rachael Panizzo 
Switching to a healthier lifestyle may reverse the signs of ageing at the genetic level in men with low-risk prostate cancer, a small study has found....

25 March 2013 - by Dr Shanya Sivakumaran 
The California Institute for Regenerative Medicine in San Francisco, USA, has awarded two multimillion-dollar grants to Cellular Dynamics International in Wisconsin and Coriell Institute for Medical Research in New Jersey to generate and bank iPS cell lines....
10 December 2012 - by Paola Quattroni 
Ten drugs companies and 23 European universities will work to develop a stem cell bank that researchers will use in fundamental disease research and to test potential new medicines...
12 November 2012 - by Dr Rachael Panizzo 
The Wellcome Trust and Medical Research Council have announced a £12.75 million investment to create a database of induced pluripotent stem) cells....
21 March 2011 - by MacKenna Roberts 
The UK Stem Cell Bank (UKSCB) has announced it has forged an affiliation with the recently established University of Massachusetts (UMASS) Human Stem Cell Bank and Registry for the exchange of stem cell technology and expertise. The banks will collaborate on various aspects of stem cell banking, including best practice standards and the delivery of stem cell lines for clinical use...

HAVE YOUR SAY
Comment (ibrahim0103 - Updated on 20/03/2014)
Induced pluripotent stem cells(IPSC) is a great and nice technology in medical science.IPSC can be generated directly from adult cells. Ipsc making human body available for research.IPSC banking system is very good for store people cell for possible future use.Using IPCS technology people may live young (age is not fact).Also IPCS technology may be used in human diseases.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Moving the Boundaries of Human Reproduction

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Jacques Cohen

Dr Anna Smajdor

Dr Andy Greenfield

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation